Ozone Gel Application in Controlled Type 2 Diabetic Patients With Periodontitis
Launched by CAIRO UNIVERSITY · Sep 9, 2022
Trial Information
Current as of May 14, 2025
Unknown status
Keywords
ClinConnect Summary
The aim of this study is to compare the effect of using ozone gel as a locally delivered adjunct to scaling and root planning versus scaling and root planning alone on the clinical parameters in stageIII grade B in periodontitis patients with controlled diabetic patients.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • 1. Patient with controlled diabetic type II. (HgA1C \<7) (Mori et al., 2021)
- • 2. Adult patients above 18 years old.
- • 3. Patients with stage III and grade B periodontitis.
- • 4. Patients accept 3-months follow-up period (cooperative patients).
- • 5. Patients provide an informed consent
- Exclusion Criteria:
- • 1. Presence of prosthetic crowns. 2. Extensive restorations. 3. Periodontal therapy within the last 12 months. 4. Having surgical therapy or undergoing orthodontic treatment. 5. Ongoing drug therapy that might have an impact on the clinical signs and symptoms of periodontitis.
- • 6. The use of antibiotics or anti-inflammatory drugs 1 month prior to the procedure and till the end of 3 months of follow-up.
- • 7. Smokers. 8. Pregnant females. 9. Any known allergies
About Cairo University
Cairo University, a premier institution in Egypt, is dedicated to advancing medical research and education through innovative clinical trials. With a strong emphasis on improving healthcare outcomes, the university collaborates with various stakeholders to conduct rigorous scientific studies that address critical health challenges. Leveraging its extensive resources and expert faculty, Cairo University aims to contribute valuable insights to the medical community and enhance patient care both locally and globally. Through its commitment to ethical research practices and excellence, the university plays a pivotal role in shaping the future of healthcare in the region.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Cairo, Manial, Egypt
Patients applied
Trial Officials
Abeer A Barahim, BDS
Principal Investigator
Master student
Nesma M Shemais, PhD
Study Director
Lecture of oral medicine and periodontology, faculty of dentistry ,Cairo university
Mona S Darhous, PhD
Study Chair
Professor of oral medicine and periodontology factuality of Dentistry,Cairo university
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials